Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Caelyx pegylated liposomal

Caelyx pegylated liposomal 2 mg/ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 11–12

HOS-085575 · Präparat HOS-083155

11  Cardiotoxicity Rare Ventricular arrhythmia Bundle branch block right Conduction disorder Atrioventricular block Cyanosis Vascular disorders Common Hypertension Hypotension Flushing Uncommon Pulmonary embolism Infusion site necrosis (including soft tissue necrosis and skin necrosis) Phlebitis Orthostatic hypotension Rare Thrombophlebitis Venous thrombosis Vasodilatation Respiratory, thoracic Common Dyspnoea and mediastinal Dyspnoea exertional disorders Epistaxis Cough Uncommon Asthma Chest discomfort Rare Throat tightness Not Known Interstitial lung disease Gastrointestinal Very common Stomatitis disorders Nausea Vomiting Diarrhoea Constipation Common Gastritis Aphthous stomatitis Mouth ulceration Dyspepsia Dysphagia Oesophagitis Abdominal pain Abdominal pain upper Oral pain Dry mouth Uncommon Flatulence Gingivitis Rare Glossitis Lip ulceration Skin and subcutaneous Very common Palmar plantar erythrodysaesthesia tissue disorders syndromea Rash (including erythematous, maculo-papular, and papular) Alopecia Common Skin exfoliation Blister Dry skin Erythema Pruritus

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.